SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Dublin, Jan. 04, 2017 -- Research and Markets has announced the addition of the "Endometriosis - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for Endometriosis in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World.
Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
The report profiles 38 companies including many key and niche players such as
- AbbVie Inc. (US)
- AEterna Zentaris Inc. (Canada)
- Astellas Pharma Inc. (Japan)
- AstraZeneca Plc. (UK)
- Bayer HealthCare Pharmaceuticals, Inc. (US)
- Debiopharm Group (Switzerland)
- Evotec AG (Germany)
- Kissei Pharmaceutical Co., Ltd. (Japan)
- Neurocrine Biosciences, Inc. (US)
- ObsEva SA (Switzerland)
- Pfizer, Inc. (US)
- Repros Therapeutics, Inc. (US)
- Roivant Sciences Ltd. (US)
- Takeda Pharmaceutical Company Limited (Japan)
- ValiRx Plc (UK)
Key Topics Covered:
1. Industry Overview
2. Endometriosis & Its Treatment - An Overview
3. Treatment Of Endometriosis
4. Select Clinical Trials/Product Innovations & Approvals
5. Recent Industry Activity
6. Focus On Select Global Players
7. Global Market Perspective
Total Companies Profiled: 38 (including Divisions/Subsidiaries 40)
- The United States (11)
- Canada (3)
- Japan (6)
- Europe (15)
- - France (1)
- - Germany (3)
- - The United Kingdom (2)
- - Rest of Europe (9)
- Asia-Pacific (Excluding Japan) (4)
- Middle-East (1)
For more information about this report visit http://www.researchandmarkets.com/research/qwzt5g/endometriosis
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Women's Health
